From: Healthcare reform in the United States and China: pharmaceutical market implications
2010 | 2015 | 2020 | ||||
---|---|---|---|---|---|---|
Population | Rx (per capita) | Population | Rx (per capita) | Population | Rx (per capita) | |
Under 26 | 108,528,000 | 110,205,000 | 110,680,000 | |||
Private insurance | 63,602,000 | 209 | 68,737,000 | 300 | 69,033,000 | 431 |
Public insurance only | 32,192,000 | 368 | 37,139,000 | 528 | 37,631,000 | 758 |
Uninsured | 12,734,000 | 109 | 4,329,000 | 156 | 4,016,000 | 225 |
26-64 | 158,889,000 | 163,463,000 | 167,247,000 | |||
Private Insurance | 115,778,000 | 915 | 127,838,000 | 1,314 | 136,923,000 | 1,886 |
Public Insurance only | 15,619,000 | 2,376 | 22,558,000 | 3,411 | 23,582,000 | 4,897 |
Uninsured | 27,492,000 | 275 | 13,068,000 | 395 | 6,742,000 | 567 |
65 and over | 41,158,000 | 47,695,000 | 55,969,000 | |||
Medicare only | 15,683,000 | 2,036 | 18,174,000 | 2,923 | 21,327,000 | 4,196 |
Medicare and private | 20,799,000 | 2,350 | 24,102,000 | 3,374 | 28,284,000 | 4,843 |
Medicare and other public | 4,062,000 | 2,953 | 4,707,000 | 4,239 | 5,524,000 | 6,086 |
Uninsured | 614,000 | 1,577 | 711,000 | 2,264 | 835,000 | 3,250 |
Total | 308,575,000 | 270,907 | 321,363,000 | 446,956 | 333,896,000 | 699,517 |